HANGER ORTHOPEDIC GROUP INC·4

Nov 25, 3:57 PM ET

JPMP MASTER FUND MANAGER L P 4

4 · HANGER ORTHOPEDIC GROUP INC · Filed Nov 25, 2003

Insider Transaction Report

Form 4
Period: 2003-11-21
Transactions
  • Sale

    7% Redeemable Preferred Stock

    2003-11-21$1425.36/sh22,119$31,527,53827,881 total(indirect: (FN 1))
    Exercise: $16.50From: 2003-11-21Non-Voting Common Stock (1,340,545 underlying)
Footnotes (5)
  • [F1]The amounts show in Table II represent the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners ("BHCA"), L.P. ("JPM BHCA"), a portion of which may be deemed attributable to the Reporting Person because it is the sole general partner of JPM BHCA. The actual pro rata portion of such beneficial ownership that may be deemed attributable to the reporting person is not readily determinable because it is subject to several variables, including thye internal rate or return and vesting within JPM BHCA.
  • [F2]The Company is entitled to require the 7% Redeemable Preferred Stock to be converted into non-voting common stock on or after July 2, 2002, if the average closing price of the common stock for 20 consecutive trading days is equal to or greater than 175% of the conversion price.
  • [F3]These shares were initially convertible into 1,340,545 shares on non-voting common stock of the Issuer. However, accrued and unpaid dividends on the 7% Redeemable Preferred Stock will have the effect of increasing the number of shares of common stock issuable upon conversion of the 7% Redeemable Preferred Stock.
  • [F4]These shares were initially convertible into 1,689,756 shares of non-voting common stock of the Issuer. However, accrued and unpaid dividends on the 7% Redeemable Preferred Stock will have the effect of increasing the number of shares of common stock issuable upon conversion of the 7% Redeemable Preferred Stock.
  • [F5]There is no expiration date.

Documents

1 file
  • 4
    c30021_form4ex.xmlPrimary